Acta Med. 2007, 50: 177-181

Clinical Use of Magnetic Resonance Imaging for the Diagnosis of Acute Myocardial Infarction in the Survivors of Cardiac Arrest

Miroslav Solařa, Jan Žižkab, Jiří Cerala, Ludovít Klzob, Petr Pařízeka

aCharles University in Prague, Faculty of Medical in Hradec Králové, 1st Department of Internal Medicine, and University Hospital Hradec Králové, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medical in Hradec Králové, Department of Diagnostic Radiology, and University Hospital Hradec Králové, Hradec Králové, Czech Republic

Received June 1, 2007
Accepted June 1, 2007


1. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21(18):1502–13.
2. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114(10):e385–484. Notes: 10.1161/CIRCULATIONAHA. 106.178233.
3. Abdel-Aty H, Zagrosek A, Schulz-Menger J et al. Delayed Enhancement and T2- weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction. Circulation 2004; 109(20):2411–6. Notes: 10.1161/01.CIR.0000127428.10985.C6. <>
4. Al-Khatib SM, Granger CB, Huang Y et al. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation 2002; 106(3):309–12. <>
5. Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular cardiovascular devicerelated infections. Circulation 2003; 108(16):2015–31. Notes: CORPORATE NAME: AHA. <>
6. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117(1):151–9. <>
7. Fieno DS, Kim RJ, Chen E-L, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36(6):1985–91. <>
8. Groh WJ, Boschee SA, Engelstein ED et al. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation 1999; 100(4):387–92. <>
9. Grubb NR, Fox KA, Cawood P. Resuscitation from out-of-hospital cardiac arrest: implications for cardiac enzyme estimation. Resuscitation 1996; 33(1):35–41. <>
10. Horowitz R, Morganroth J, Parrotto C, Chen C, Soffer J, Pauletto F. Immediate diagnosis of acute myocardial infarction by two-dimensional echocardiography. Circulation 1982; 65(2):323–9. <>
11. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function. Circulation 1999; 100(19):1992–2002. <>
12. Krause T, Hohnloser SH, Kasper W, Schumichen C, Reinhardt M, Moser E. Assessment of acute myocardial necrosis after cardiopulmonary resuscitation and cardioversion by means of combined thallium-201/technetium-99m pyrophosphate tomography. Eur J Nucl Med 1995; 22(11):1286–91. <>
13. Krause T, Zeiher A, Kasper W, Schwehn M, Schumichen C, Moser E. Combined thallium 201/technetium 99m-labeled pyrophosphate tomography for identification of the „culprit“ vessel in acute myocardial infarction. J Nucl Cardiol 1996; 3(2):105–13. <>
14. Kuck K-H, Cappato R, Siebels J, Ruppel R. Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102(7):748–54. <>
15. Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR. Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med 1974; 291(7): 317–21. <>
16. Mullner M, Hirschl MM, Herkner H et al. Creatine kinase-mb fraction and cardiac troponin T to diagnose acute myocardial infarction after cardiopulmonary resuscitation. J Am Coll Cardiol 1996; 28(5):1220–5. <>
17. Mullner M, Oschatz E, Sterz F et al. The influence of chest compressions and external defibrillation on the release of creatine kinase-MB and cardiac troponin T in patients resuscitated from out-of-hospital cardiac arrest. Resuscitation 1998; 38(2):99–105. <>
18. Mullner M, Sterz F, Binder M et al. Creatine kinase and creatine kinase-MB release after nontraumatic cardiac arrest. Am J Cardiol 1996; 77(8):581–5. <>
19. Myerburg RJ. Sudden cardiac death: epidemiology, causes, and mechanisms. Cardiology 1987; 74 Suppl 2:2–9. <>
20. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119(12):1187–97. <>
21. Pleskot M, Babu A, Kajzr J et al. Characteristics and short-term survival of individuals with out-of-hospital cardiac arrests in the East Bohemian region. Resuscitation 2006; 68(2):209–20. <>
22. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002; 105(2):224–9. <>
23. Schoeder H, Topp H, Friedrich M, Jatzkewitz A, Roser M. Thallium and indium antimyosin dual-isotope single-photon emission tomography in acute myocardial infarction to identify patients at further ischaemic risk. Eur J Nucl Med 1994; 21(5):415–22. <>
24. Sears SF, Todaro JF, Urizar G et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000; 23(6):939–45. <>
25. Shan K, Constantine G, Sivananthan M, Flamm SD. Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability. Circulation 2004; 109(11):1328–34. Notes: 10.1161/01.CIR.0000120294.67948.E3. <>
26. Stork A, Muellerleile K, Bansmann PM et al. Value of T2-weighted, first-pass and delayed enhancement, and cine CMR to differentiate between acute and chronic myocardial infarction. Eur Radiol 2006.
27. Takahashi N, Inoue T, Oka T et al. Diagnostic use of T2-weighted inversion-recovery magnetic resonance imaging in acute coronary syndromes compared with 99mTc-Pyrophosphate, 123I-BMIPP and 201TlCl single photon emission computed tomography. Circ J 2004; 68(11):1023–9. <>
28. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. N Engl J Med 1997; 337(22):1576–84. Notes: 10.1056/NEJM199711273372202.
29. Volpi A, Cavalli A, Franzosi MG et al. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto miocardico) investigators. Am J Cardiol 1989; 63(17):1174–8. <>
30. Wisenberg G, Prato FS, Carroll SE, Turner KL, Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J 1988; 115(3):510–8. <>
31. Yeo KK, Cruz L, Hong R. Tachycardia-induced elevations in cardiac troponin in the absence of coronary artery disease. Hawaii Med J 2006; 65(3):86–7.
32. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104(18):2158–63. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal